Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dystrophia Myotonica 2”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Not applicableLooking for participantsNCT06918977
What this trial is testing

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

Who this might be right for
Diabetes Mellitus
University of Maryland, Baltimore 50
Not applicableUnknownNCT05446415
What this trial is testing

L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP

Who this might be right for
Severe ObesityType 2 Diabetes Mellitus in Obese
University of Sao Paulo General Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT01641939
What this trial is testing

Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 415
Not applicableStudy completedNCT07252193
What this trial is testing

Generative AI-Based Simulation for Diagnostic Communication in Type 2 Diabetes (DIALOGUE-DM2)

Who this might be right for
Type 2 Diabetes MellitusMedical EducationDiagnostic Communication+1 more
Universidad Nacional Autonoma de Mexico 120
Early research (Phase 1)Study completedNCT02073916
What this trial is testing

T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Jenny C. Chang, MD 24
Testing effectiveness (Phase 2)Looking for participantsNCT06185764
What this trial is testing

VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
Vertex Pharmaceuticals Incorporated 44
Not applicableActive Not RecruitingNCT03508934
What this trial is testing

Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Hypoglycemia
VA Office of Research and Development 218
Not applicableStudy completedNCT01447251
What this trial is testing

Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaDiabetes Mellitus
Mike O'Callaghan Military Hospital 70
Not applicableStudy completedNCT03165877
What this trial is testing

Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Universidad de Valparaiso 13
Testing effectiveness (Phase 2)Ended earlyNCT03709082
What this trial is testing

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerBreast Cancer Metastatic
University of Kansas Medical Center 3
Not applicableActive Not RecruitingNCT05874635
What this trial is testing

Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

Who this might be right for
Weight LossMetabolic SyndromeDiabetes Mellitus, Type 2+4 more
Signos Inc 20,000
Not applicableUnknownNCT02708784
What this trial is testing

An MRI Study on Muscular Diseases -Pompe Disease and Dystrophia Myotonica-

Who this might be right for
Glycogen Storage Disease Type 2Dystrophia Myotonica
University of Aarhus 60
Not applicableLooking for participantsNCT02398786
What this trial is testing

Myotonic Dystrophy Family Registry

Who this might be right for
Myotonic DystrophyCongenital Myotonic DystrophyMyotonic Dystrophy 1+13 more
Myotonic Dystrophy Foundation 3,500
Not applicableUnknownNCT03155594
What this trial is testing

CGM to Aid Transition From Inpatient to Outpatient

Who this might be right for
Diabete Mellitus
Methodist Medical Center of Illinois 15
Testing effectiveness (Phase 2)Study completedNCT00070837
What this trial is testing

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Millennium Pharmaceuticals, Inc. 46
Large-scale testing (Phase 3)Active Not RecruitingNCT03529110
What this trial is testing

DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]

Who this might be right for
Breast Cancer
Daiichi Sankyo 524
Not applicableWithdrawnNCT03277742
What this trial is testing

Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz

Who this might be right for
Pulmonary TuberculosisDiabetes Mellitus, Type 2
Instituto Nacional de Salud Publica, Mexico
Testing effectiveness (Phase 2)Ended earlyNCT03248492
What this trial is testing

DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)

Who this might be right for
Breast Cancer
Daiichi Sankyo 253
Early research (Phase 1)Study completedNCT01976169
What this trial is testing

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

Who this might be right for
Advanced Breast Cancer
University of Texas Southwestern Medical Center 29
Testing effectiveness (Phase 2)Ended earlyNCT01702558
What this trial is testing

A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)

Who this might be right for
Breast CancerGastric Cancer
Hoffmann-La Roche 182
Load More Results